Coherus Oncology, Inc.
← Back to CHRS Overview

Coherus Oncology, Inc. (CHRS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-1.14

Financial Fundamentals

CHRS • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2013-03-31-1.00
2013-06-30-1.13
2013-09-30-2.65
2013-12-31-3.91
2014-03-31-2.26
2014-06-30-2.28
2014-09-30-5.26
2014-12-31-2.78
2015-03-31-6.27
2015-06-30-4.63
2015-09-30-2.69
2015-12-31-4.27
2016-03-31-3.17
2016-06-30-2.46
2016-09-303.47
2016-12-31-4.11
2017-03-31-3.44
2017-06-30-3.33
2017-09-30-3.06
2017-12-31-2.62
2018-03-31-3.75
2018-06-30-5.13
2018-09-30-4.67
2018-12-31-2.46
2019-03-31-11.29
2019-06-3016.60
2019-09-307.52
2019-12-318.06
2020-03-318.06
2020-06-305.38
2020-09-3011.76
2020-12-3132.33
2021-03-31-1.54
2021-06-30-8.74
2021-09-30-8.20
2021-12-31-6.66
2022-03-31-2.59
2022-06-30-2.78
2022-09-30-2.16
2022-12-31-2.62
2023-03-31-1.79
2023-06-30-2.17
2023-09-30-2.31
2023-12-31-1.17
2024-03-310.66
2024-06-30-3.58
2024-09-30-2.79
2024-12-31-0.79
2025-03-31-0.41
2025-06-300.07
2025-09-30-1.34
2025-12-31-1.14

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.